glp 1 drugs for type 1 diabetes GLP-1 Costs Explained: Managing Coverage Challenges Weight-Loss Drug Use Has Risen
Description
We understand that health concerns don't always follow a convenient schedule
The GLP-1 receptor agonist market is still primarily anchored in type 2 diabetes management, where these drugs improve glycemic control, reduce HbA1c levels, and mitigate cardiovascular risks
The main goal of this document is to reach a consensus regarding patient education and procedures to minimize the frequency and intensity of GLP-1 RA-associated GI AEs
It affects a significant number of users, and for some, it can be disruptive
Patients with persistent symptoms should think about stopping their medication [10]
